Trial Profile
Study to evaluate the effects of Reslizumab on Nasal Polyp Inflammation in patients with Aspirin Exacerbated Respiratory Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2018
Price :
$35
*
At a glance
- Drugs Reslizumab (Primary)
- Indications Aspirin-induced asthma
- Focus Therapeutic Use
- 26 Mar 2018 New trial record
- 05 Mar 2018 Results presented at the 2018 Annual Meeting of the American Academy of Allergy, Asthma and Immunology